Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Active, not recruiting · NCT05904028 · Registry updated 2026-07-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2026-07-07 | NCT05904028 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jaeb Center for Health Research | 37 |
| Juvenile Diabetes Research Foundation | 33 |
| National Eye Institute (NEI) | 122 |
| National Institutes of Health (NIH) | 667 |
64 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.